Skip to content
My Account
Login
Donate
Search
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
EndoText
Home
Sections
Webinar Case Studies
Clinical Guidelines
Our Editorial Team
Our Country Associates
About
About EndoText
Education Grants
Leslie DeGroot, MD
Contact us
EndoText
Home
Sections
Webinar Case Studies
Clinical Guidelines
Our Editorial Team
Our Country Associates
About
About EndoText
Education Grants
Leslie DeGroot, MD
Contact us
Registration is Free
Diagnosis and Treatment of Diseases of Lipid and Lipoprotein Metabolism in Adults and Children
Home
»
Diagnosis and Treatment of Diseases of Lipid and Lipoprotein Metabolism in Adults and Children
Home
»
Sections
»
Diagnosis and Treatment of Diseases of Lipid and Lipoprotein Metabolism in Adults and Children
Is Atherosclerosis a Pediatric Disease
Editors:
Don P. Wilson, MD, FNLA
Guidelines for Screening, Prevention, Diagnosis, and Treatment of Dyslipidemia in Children and Adolescents
Editors:
Stephen R. Daniels, MD, PhD
Approach to the Patient with Dyslipidemia
Editors:
Kenneth R. Feingold, MD
Triglyceride Lowering Drugs
Editors:
Kenneth R. Feingold, MD
The Effect of Inflammation and Infection on Lipids and Lipoproteins
Editors:
Kenneth R. Feingold, MD
Risk of Fasting and Non-Fasting Hypertriglyceridemia in Coronary Vascular Disease and Pancreatitis
Editors:
Andrew Messersmith, MD, MPH
Dyslipidemia in Chronic Kidney Disease
Editors:
Steven Lacount, DO
Guidelines for the Management of High Blood Cholesterol
Editors:
Kenneth R. Feingold, MD
Dysbetalipoproteinemia (Type III Hyperlipoproteinemia)
Editors:
Weerapan Khovidhunkit, MD, PhD
Familial Hypercholesterolemia: Genes and Beyond
Editors:
Bruce A. Warden PharmD, BCPS-AQ Cardiology, CLS, FNLA, FASPC
Lipodystrophy Syndromes: Presentation and Treatment
Editors:
Baris Akinci
Clinical Management of Dyslipidemia in Youth with Chronic Kidney Disease
Editors:
Alejandro De La Torre, MD
Load More
No more entries
BACKGROUND
Introduction to Lipids and Lipoproteins
Kenneth R. Feingold, MD
Utility of Advanced Lipoprotein Testing in Clinical Practice
Kenneth R. Feingold, MD
The Role of Lipids and Lipoproteins in Atherosclerosis
MacRae F. Linton, MD, Patricia G. Yancey, PhD, Sean S. Davies, PhD, W. Gray (Jay) Jerome, PhD, Edward F. Linton, BA, Wenliang L. Song, MD, Amanda C. Doran, PhD, MD, Kasey C. Vickers, PhD
Guidelines for the Management of High Blood Cholesterol
Kenneth R. Feingold, MD
Risk of Fasting and Non-Fasting Hypertriglyceridemia in Coronary Vascular Disease and Pancreatitis
Andrew Messersmith, MD, MPH, Rahul Purbey, MD, Lisa R. Tannock, MD
GENETIC DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM
Familial Hypercholesterolemia: Genes and Beyond
Bruce A. Warden PharmD, BCPS-AQ Cardiology, CLS, FNLA, FASPC, Sergio Fazio MD, PhD, Michael D. Shapiro, DO, MCR
Hypertriglyceridemia: Pathophysiology, Role of Genetics, Consequences, and Treatment
Savitha Subramanian, MD
Dysbetalipoproteinemia (Type III Hyperlipoproteinemia)
Weerapan Khovidhunkit, MD, PhD
Lysosomal Acid Lipase Deficiency
Nivedita Patni, MD
Sitosterolemia
Ann Liebeskind, MD, Amy L. Peterson, MD, MS
Cerebrotendinous Xanthomatosis
Nivedita Patni, MD
Lipoprotein (a)
Weerapan Khovidhunkit, MD, PhD
Monogenic Disorders Causing Hypobetalipoproteinemia
Michael D. Shapiro, DO, MCR, Kenneth R. Feingold, MD
Monogenic Disorders Altering HDL Levels
Michael D. Shapiro, DO, MCR, Kenneth R. Feingold, MD
Lipodystrophy Syndromes: Presentation and Treatment
Baris Akinci, Merve Celik Guler, Elif A. Oral
SECONDARY DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM AND SPECIAL POPULATIONS
Dyslipidemia in Patients With Diabetes
Kenneth R. Feingold, MD
Dyslipidemia in Chronic Kidney Disease
Steven Lacount, DO, Lisa R. Tannock, MD
Lipid and Lipoprotein Metabolism in Liver Disease
David E. Cohen MD, PhD, Kathleen E. Corey MD MPH, MMSc
The Effect of Endocrine Disorders on Lipids and Lipoproteins
Kenneth R. Feingold, MD
The Effect of Inflammation and Infection on Lipids and Lipoproteins
Kenneth R. Feingold, MD, Carl Grunfeld, MD, PhD
Lipid Disorders In People With HIV
Sudipa Sarkar, MD, MSCI, Todd T. Brown MD, PhD
Lipid and Lipoprotein Levels in Patients with Covid-19 Infections
Kenneth R. Feingold, MD
Medication Induced Changes in Lipid and Lipoproteins
Megan Herink, Pharm.D., BCPS, Matthew K. Ito, Pharm.D., FCCP, FNLA, CLS.
Obesity and Dyslipidemia
Kenneth R. Feingold, MD
Evaluation and Treatment of Dyslipidemia in the Elderly
Elani Streja, Ph.D., Kenneth R. Feingold, MD
Effect of Pregnancy on Lipid Metabolism and Lipoprotein Levels
Robert Wild, MD, MPH, PhD, Kenneth R. Feingold, MD
TREATMENT
Approach to the Patient with Dyslipidemia
Kenneth R. Feingold, MD
The Effect of Diet on Cardiovascular Disease and Lipid and Lipoprotein Levels
Kenneth R. Feingold, MD
Cholesterol Lowering Drugs
Kenneth R. Feingold, MD
Triglyceride Lowering Drugs
Kenneth R. Feingold, MD
Lipoprotein Apheresis
Kenneth R. Feingold, MD
PEDIATRIC LIPIDOLOGY
BACKGROUND
Is Atherosclerosis a Pediatric Disease
Don P. Wilson, MD, FNLA
Fetal and Neonatal Sterol Metabolism
Laura A. Woollett, Amy S. Shah, MD MS, FNLA
Non-Invasive Techniques In Pediatric Dyslipidemia
Damon B. Dixon, MD
Genetic Testing in Youth – A Primer for Pediatric Lipidologists
Luke Hamilton, MS
Genetics and Dyslipidemia
Nivedita Patni, MD, Zahid Ahmad, MD
SCREENING AND GUIDELINES
Guidelines for Screening, Prevention, Diagnosis, and Treatment of Dyslipidemia in Children and Adolescents
Stephen R. Daniels, MD, PhD
Lipid Screening in Youth
Justin P. Zachariah MD MPH
Understanding Ethical Dilemmas in Pediatric Lipidology- Genetic Testing in Youth
G. Kevin Donovan, MD, MA
Reproductive Health and Its Impact On Lipid Management in Adolescent and Young Adult Females
Ann Liebeskind, MD, Jennifer Thompson, MD, Don Wilson, MD
HYPERCHOLESTEROLEMIA
Familial Hypercholesterolemia
Amy E. Levenson, MD, Sarah D. de Ferranti, MD, MPH
Lysosomal Acid Lipase Deficiency
Don P. Wilson, MD, FNLA, Nivedita Patni, MD
Sitosterolemia
Ann Liebeskind, MD, Amy L. Peterson, MD, MS, Don P. Wilson, MD, FNLA
Cerebrotendinous Xanthomatosis
Nivedita Patni, MD
Lipoprotein (a) in Youth
Catherine J. McNeal, MD, PhD, Amy L. Peterson, MD, MS
HYPERTRIGLYCERIDEMIA
Genetic Disorders Causing Hypertriglyceridemia in Children and Adolescents
Amy S. Shah, MD MS, FNLA, Don P. Wilson, MD, FNLA
Secondary Hypertriglyceridemia
Irwin Benuck, MD, PhD, Catherine J. McNeal, MD, PhD
Combined Dyslipidemia in Children and Adolescents
Rae-Ellen W. Kavey, MD, MPH.
TREATMENT
Leslie J. De Groot, MD
Nutritional Management of Pediatric Dyslipidemia
Lauren A. Williams, MCN, RDN, LD
Use of Lipid Lowering Medications in Youth
Melissa L Miller, PharmD, Amina Mujkic, PharmD, Chanin C Wright, PharmD.
Management of Hospitalized Children with Severe Hypertriglyceridemia
Alejandro De La Torre, MD, Luke Hamilton, MS, Don P. Wilson, MD, FNLA
Clinical Management of Dyslipidemia in Youth with Chronic Kidney Disease
Alejandro De La Torre, MD, Nivedita Patni, MD
The Role Of Parents In The Care Of Children With Dyslipidemia
Gabriella Webster, MS, Melissa Scarcelli, RN, Brenda Sonnier, CCLS, Luke Hamilton, MS, Don P. Wilson, MD, FNLA